Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO).

Ylisaukko-Oja T, Aaltonen J, Nuutinen H, Blomster T, Jussila A, Pajala M, Salminen K, Moilanen V, Hakala K, Kellokumpu M, Toljamo K, Rautiainen H, Kuisma J, Peräaho M, Molander P, Silvennoinen J, Liukkonen V, Henricson H, Tillonen J, Esterinen M, Nielsen C, Hirsi E, Lääne M, Suhonen UM, Vihriälä I, Mäkelä P, Puhto M, Punkkinen J, Sulonen H, Herrala S, Jokelainen J, Tamminen K, Sipponen T.

Scand J Gastroenterol. 2018 Feb;53(2):158-167. doi: 10.1080/00365521.2017.1416160. Epub 2017 Dec 19.

PMID:
29258369
2.

Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series.

Lahtinen P, Mattila E, Anttila VJ, Tillonen J, Teittinen M, Nevalainen P, Salminen S, Satokari R, Arkkila P.

World J Gastroenterol. 2017 Oct 21;23(39):7174-7184. doi: 10.3748/wjg.v23.i39.7174.

3.

Gliadin antibodies in older population and neurological and psychiatric disorders.

Ruuskanen A, Kaukinen K, Collin P, Krekelä I, Patrikainen H, Tillonen J, Nyrke T, Laurila K, Haimila K, Partanen J, Valve R, Mäki M, Luostarinen L.

Acta Neurol Scand. 2013 Jan;127(1):19-25. doi: 10.1111/j.1600-0404.2012.01668.x. Epub 2012 Apr 12.

PMID:
22494246
4.

Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.

Ruuskanen A, Luostarinen L, Collin P, Krekelä I, Patrikainen H, Tillonen J, Laurila K, Haimila K, Partanen J, Mäki M, Valve R, Kaukinen K.

Dig Liver Dis. 2011 Oct;43(10):772-8. doi: 10.1016/j.dld.2011.04.025. Epub 2011 Jun 8.

PMID:
21641886
5.

Microbes and mucosa in the regulation of intracolonic acetaldehyde concentration during ethanol challenge.

Visapää JP, Tillonen J, Salaspuro M.

Alcohol Alcohol. 2002 Jul-Aug;37(4):322-6.

PMID:
12107032
6.

4-Methylpyrazole decreases salivary acetaldehyde levels in aldh2-deficient subjects but not in subjects with normal aldh2.

Väkeväinen S, Tillonen J, Salaspuro M.

Alcohol Clin Exp Res. 2001 Jun;25(6):829-34.

PMID:
11410717
7.

Acetaldehyde production and other ADH-related characteristics of aerobic bacteria isolated from hypochlorhydric human stomach.

Väkeväinen S, Tillonen J, Blom M, Jousimies-Somer H, Salaspuro M.

Alcohol Clin Exp Res. 2001 Mar;25(3):421-6.

PMID:
11290854
8.

Poor dental status increases acetaldehyde production from ethanol in saliva: a possible link to increased oral cancer risk among heavy drinkers.

Homann N, Tillonen J, Rintamäki H, Salaspuro M, Lindqvist C, Meurman JH.

Oral Oncol. 2001 Feb;37(2):153-8.

PMID:
11167142
9.

Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol.

Väkeväinen S, Tillonen J, Salaspuro M, Jousimies-Somer H, Nuutinen H, Färkkilä M.

Aliment Pharmacol Ther. 2000 Nov;14(11):1511-8.

10.

High salivary acetaldehyde after a moderate dose of alcohol in ALDH2-deficient subjects: strong evidence for the local carcinogenic action of acetaldehyde.

Väkeväinen S, Tillonen J, Agarwal DP, Srivastava N, Salaspuro M.

Alcohol Clin Exp Res. 2000 Jun;24(6):873-7.

PMID:
10888077
11.

Metronidazole increases intracolonic but not peripheral blood acetaldehyde in chronic ethanol-treated rats.

Tillonen J, Väkeväinen S, Salaspuro V, Zhang Y, Rautio M, Jousimies-Somer H, Lindros K, Salaspuro M.

Alcohol Clin Exp Res. 2000 Apr;24(4):570-5.

PMID:
10798595
12.

Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer.

Homann N, Tillonen J, Meurman JH, Rintamäki H, Lindqvist C, Rautio M, Jousimies-Somer H, Salaspuro M.

Carcinogenesis. 2000 Apr;21(4):663-8.

PMID:
10753201
13.
14.

Role of yeasts in the salivary acetaldehyde production from ethanol among risk groups for ethanol-associated oral cavity cancer.

Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M.

Alcohol Clin Exp Res. 1999 Aug;23(8):1409-15.

PMID:
10470985
15.

Ciprofloxacin decreases the rate of ethanol elimination in humans.

Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M.

Gut. 1999 Mar;44(3):347-52.

16.

Role of catalase in in vitro acetaldehyde formation by human colonic contents.

Tillonen J, Kaihovaara P, Jousimies-Somer H, Heine R, Salaspuro M.

Alcohol Clin Exp Res. 1998 Aug;22(5):1113-9.

PMID:
9726283

Supplemental Content

Loading ...
Support Center